UK Medical Resident is Contributing Author in Neurodevelopmental Disorders Textbook

LEXINGTON, Ky. (Oct. 21, 2014) -- Dr. Ruhel Boparai, resident in the University of Kentucky's Department of Psychiatry, is a contributing author on one of the chapters in "Treatment of Neurodevelopmental Disorders: Targeting Neurobiological Mechanisms."

The book brings advances in genetics, neurobiology, and psychopharmacology to the clinic to enhance treatment for neurodevelopmental disorders.

Boparai assisted in the writing of fourth chapter, entitled "Neurodevelopmental and Neurobiological Aspects of Major Depression: From theory to therapy."

"Significant progress has been made in identifying the neurobiological mechanisms of several disorders," Boparai said. "However, the ability to utilize this knowledge has not been summarized in one place for the practicing clinician. This book will fill that gap by providing the theoretical underpinnings and the latest advances in targeted treatments."

Several neurodevelopmental disorders are reviewed in detail including clinical features and behavioral phenotypes, standard treatments and new targeted treatments based on the latest advances in neurobiology and the animal model studies that have lead to new treatments.

The disorders covered include psychiatric disorders: schizophrenia, depression, autism and ADHD; single gene disorders including Tuberous Sclerosis, Fragile X Syndrome and fragile X- associated disorders, Angelman Syndrome, PKU, and Muscular Dystrophies; and complex genetic disorders such as Down syndrome. This book also highlights the commonalities across disorders and new genetic and molecular concepts.

More information can be found at http://ukcatalogue.oup.com/product/9780199937806.do